Aspira Women's Health (AWH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Executive summary
Annual meeting scheduled for June 17, 2026, with voting available online or in person.
Proxy materials and the 2025 Annual Report are accessible online or by request before June 3, 2026.
Voting matters and shareholder proposals
Election of six director nominees is up for shareholder vote.
Advisory vote on executive compensation (say-on-pay) is included.
Amendment to the 2019 Stock Incentive Plan proposed for approval.
Ratification of BDO USA PC as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Director nominees include Ellen Beausang, Jeffrey Cohen, M.D., John Fraser, Cynthia Hundorfean, Winfred Parnell, M.D., and Jane Pine Wood.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Aspira Women's Health
- Proxy covers director elections, executive pay, stock plan amendment, and auditor ratification.AWH
Proxy filing24 Apr 2026 - Flat revenue, improved margins, and halved operating loss, but significant going concern risk remains.AWH
Q4 20251 Apr 2026 - AI-driven diagnostics advance women's health, improving outcomes and financial performance.AWH
Investor presentation16 Mar 2026 - OvaSuite test volume and efficiency rose, but losses and liquidity risks persist in Q2 2024.AWH
Q2 20241 Feb 2026 - $10M ARPA-H funding accelerates AI-powered, non-invasive diagnostics for a $1B+ market.AWH
Investor Day 202418 Jan 2026 - OvaSuite revenue up 2%, OvaWatch volume up 27%, ARPA-H grant secured, liquidity risks remain.AWH
Q3 202414 Jan 2026 - Up to $10M in equity financing may be drawn, supporting AI-driven diagnostics but causing dilution.AWH
Registration Filing31 Dec 2025 - Resale registration for 2.57M shares via warrants supports capital needs amid Nasdaq listing risk.AWH
Registration Filing16 Dec 2025 - Registers 2.5M shares for resale; faces Nasdaq delisting risk and going concern warning.AWH
Registration Filing16 Dec 2025